Expertise in

conditions

Marta Mosca

Pisa, IT

Expertise in

conditions

Pisa, IT

Overview

Marta Mosca practices practicing medicine in Pisa, Italy.

Ms. Mosca is highly rated in 40 conditions, according to our data. Her clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Behcet Disease, Myositis, Osteotomy, and Kidney Transplant.

She is actively involved in clinical research, co-authoring 412 peer reviewed articles and participating in 4 clinical trials.

Gender

Female

Locations

Pisa, Italy

Other Locations

L'aquila, Italy

Siena, Italy

Bologna, 40136, Italy

Bentivoglio, Italy

Pisana, Italy

Modena, Italy

Bo, Italy

Italy

Trieste, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)

Enrollment Status: Completed

Publish Date: March 20, 2026

Intervention Type: Other, Biological

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)

Enrollment Status: Terminated

Publish Date: May 16, 2023

Intervention Type: Drug

Study Drug: Baricitinib

Study Phase: Phase 3

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus

Enrollment Status: Completed

Publish Date: November 23, 2022

Intervention Type: Drug

Study Drug: Baricitinib

Study Phase: Phase 3

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis

Enrollment Status: Completed

Publish Date: August 16, 2022

Intervention Type: Drug

Study Drug: Lenabasum

Study Phase: Phase 3

View 3 Less Clinical Trials

412 Total Publications

Introduction to the issue: Cellular therapies in rheumatology.

Journal: Best practice & research. Clinical rheumatology

Published: May 07, 2026

View All 412 Publications

Frequently Asked Questions about Marta Mosca

Is Marta Mosca a top-rated expert for Systemic Lupus Erythematosus (SLE)?

MediFind is an objective health platform that identifies experts based on real-world data. Marta Mosca is classified as an Elite expert for Systemic Lupus Erythematosus (SLE), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Marta Mosca participate in research or clinical trials?

Yes. Marta Mosca has published 412 articles and abstracts on conditions like Systemic Lupus Erythematosus (SLE). You can view a list of Marta Mosca's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Mosca's expertise for a condition

ConditionClose